𝔖 Bobbio Scriptorium
✦   LIBER   ✦

110 RAT BONE MARROW DERIVED MESENCHYMAL STEM CELL THERAPY IN A PARKINSONIAN ANIMAL MODEL OF DETRUSOR OVERACTIVITY

✍ Scribed by Campeau, Lysanne; Soler, Roberto; Pareta, Rajesh; Sivanandane, Sittadjody; Opara, Emmanuel; Andersson, Karl Erik

Book ID
118484798
Publisher
Lippincott Williams and Wilkins
Year
2012
Tongue
English
Weight
59 KB
Volume
187
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Survival of bone marrow-derived mesenchy
Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model
✍ Yan Wang; Xi Chen; Marilyn Ann Armstrong; Gang Li πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 406 KB πŸ‘ 1 views

## Abstract Mesenchymal stem cells (MSCs) are immunoprivileged and the allogeneic MSCs implantation has been used to facilitate tissue repairs such as bone and cartilage defect. The present study aimed to investigate the feasibility of xenogeneic MSCs implantation. Green fluorescent protein (GFP) t

Glial cell line-derived neurotrophic fac
Glial cell line-derived neurotrophic factor–secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease
✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 456 KB πŸ‘ 1 views

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem